Drug Shortage Report for ETODOLAC
Report ID | 2001 |
Drug Identification Number | 02232317 |
Brand name | ETODOLAC |
Common or Proper name | ETODOLAC |
Company Name | AA PHARMA INC |
Market Status | DORMANT |
Active Ingredient(s) | ETODOLAC |
Strength(s) | 200 MG |
Dosage form(s) | Capsule |
Route of administration | Oral |
Packaging size | 100 Bottle |
ATC code | M01AB |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2016-04-13 |
Estimated end date | 2017-08-09 |
Actual end date | 2017-06-12 |
Shortage status | Resolved |
Updated date | 2017-09-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2017-09-05 | French | Compare |
v12 | 2017-09-05 | English | Compare |
v11 | 2017-05-02 | French | Compare |
v10 | 2017-05-02 | English | Compare |
v9 | 2017-04-26 | French | Compare |
v8 | 2017-04-26 | English | Compare |
v7 | 2017-04-05 | French | Compare |
v6 | 2017-04-05 | English | Compare |
v5 | 2017-03-15 | French | Compare |
v4 | 2017-03-15 | English | Compare |
v3 | 2017-03-14 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 13 of 13